CSIMarket
 
Vaxcyte Inc   (NASDAQ: PCVX)
 

Vaxcyte Inc's Suppliers Performance

PCVX's Supply Chain




 
PCVX Costs vs Sales of Suppliers Growth

• More on PCVX Suppliers






Vaxcyte Inc's Comment on Supply Chain


The company manufactures the eCRM protein using raw materials such as E. coli extracts and lysates for in vitro DNA transcription and translation. Pneumococcal polysaccharides are isolated from Streptococcus pneumoniae strains cultured in bioreactors through a standardized fed-batch process. Conjugate drug substances are produced by conjugating activated pneumococcal polysaccharide strains to the eCRM protein using click chemistry. Final drug products are formulated, adsorbed onto alum, filled into vials, and refrigerated. The company does not own manufacturing facilities but maintains strategic partnerships with Lonza and other contract manufacturing organizations (CMOs) for the production of eCRM, polysaccharides, drug substances, and final drug products. Agreements with Lonza provide capacity, expertise, and commercial manufacturing support, while an agreement with Sutro Biopharma supplies extracts and custom reagents used in eCRM manufacturing.

Vaxcyte Inc's Comment on Supply Chain


The company manufactures the eCRM protein using raw materials such as E. coli extracts and lysates for in vitro DNA transcription and translation. Pneumococcal polysaccharides are isolated from Streptococcus pneumoniae strains cultured in bioreactors through a standardized fed-batch process. Conjugate drug substances are produced by conjugating activated pneumococcal polysaccharide strains to the eCRM protein using click chemistry. Final drug products are formulated, adsorbed onto alum, filled into vials, and refrigerated. The company does not own manufacturing facilities but maintains strategic partnerships with Lonza and other contract manufacturing organizations (CMOs) for the production of eCRM, polysaccharides, drug substances, and final drug products. Agreements with Lonza provide capacity, expertise, and commercial manufacturing support, while an agreement with Sutro Biopharma supplies extracts and custom reagents used in eCRM manufacturing.







PCVX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Vaxcyte Inc 8,221.71 0.00 -1,064.26 507
SUBTOTAL 0.00 0.00 0.00 -


Sources: Vaxcyte Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Vaxcyte Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.